Summary/Conclusion
IOERT boost during surgery not only enables good local control without geometric miss of the tumor, but also delivers good cosmetic effect after therapy.
Read MoreView Clinical research and studies by
October 8, 2012
Forouzannia, A. et al., “Intraoperative Electron Radiotherapy Boost as a Component of Adjuvant Radiation for Breast Cancer in the Community Setting.” (2012)
Summary/Conclusion
IOERT resulted in a reduction of treatment time, was not associated with additional toxicity or change in the acute toxicity profile, and is a feasible treatment option in a community setting.
Read MoreJuly 20, 2012
Usychkin, S. et al., “IOERT for Newly Diagnosed and Recurrent Malignant Gliomas: Feasibility and Long-term Outcomes.” (2013)
Summary/Conclusion
IOERT is a feasible technique and can be viewed as a tool in the treatment of newly diagnosed and recurrent brain gliomas.
Read MoreJune 6, 2012
Tamaki, Y. et al., “Efficacy of Intraoperative Radiotherapy Targeted to the Abdominal Lymph Node Area in Patients with Esophageal Carcinoma.” (2012)
Summary/Conclusion
Both univariate and multivariate analysis revealed the survival rate was significantly higher in patients that received IORT than in those that did not (p = 0.026). There were no perioperative complications attributed to IORT. IORT for esophageal carcinoma will likely be effective for patients with a primary lesion in the lower thoracic or abdominal esophagus, or with a long lesion.
Read MoreMarch 5, 2012
“Accelerated Partial Breast Irradiation Using Only Intraoperative Electron Radiation Therapy in Early Stage Breast Cancer.”
Cancer Indication
Number of Patients
226
Summary/Conclusion
APBI using a single dose of IOERT can be delivered safely in women with early, low-risk breast cancer in carefully selected patients.
Read More